These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pathological changes in the pancreas of fulminant type 1 diabetes and slowly progressive insulin-dependent diabetes mellitus (SPIDDM): innate immunity in fulminant type 1 diabetes and SPIDDM. Kobayashi T; Nishida Y; Tanaka S; Aida K Diabetes Metab Res Rev; 2011 Nov; 27(8):965-70. PubMed ID: 22069294 [TBL] [Abstract][Full Text] [Related]
4. Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes. Ferber KM; Keller E; Albert ED; Ziegler AG J Clin Endocrinol Metab; 1999 Jul; 84(7):2342-8. PubMed ID: 10404800 [TBL] [Abstract][Full Text] [Related]
5. [Prediction and prevention of type I diabetes]. Takino H; Yamaguchi Y; Nagataki S Nihon Rinsho; 1997 Nov; 55 Suppl():313-8. PubMed ID: 9434486 [No Abstract] [Full Text] [Related]
8. C-peptide: an index of insulin secretion. Faber OK; Binder C Diabetes Metab Rev; 1986; 2(3-4):331-45. PubMed ID: 3527619 [TBL] [Abstract][Full Text] [Related]
9. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I. Tuomi T; Björses P; Falorni A; Partanen J; Perheentupa J; Lernmark A; Miettinen A J Clin Endocrinol Metab; 1996 Apr; 81(4):1488-94. PubMed ID: 8636356 [TBL] [Abstract][Full Text] [Related]
10. Presence of insulin autoantibodies at clinical diagnosis of diabetes mellitus type I predicts loss of beta cell function. Gomis R; Recasesns A; Peig M; Casamitjana R; Pujol-Borrell R; Rivera F; Vilardell E Autoimmunity; 1988; 1(4):299-305. PubMed ID: 2979623 [TBL] [Abstract][Full Text] [Related]
11. Immune mechanisms leading to type 1 insulin-dependent diabetes mellitus. Boitard C; Timsit J; Larger E; Dubois D Horm Res; 1997; 48 Suppl 4():58-63. PubMed ID: 9350450 [TBL] [Abstract][Full Text] [Related]
16. Insulin secretion and anti-GAD65 antibodies in subjects with impaired glucose tolerance. Tankova T; Dakovska L; Kirilov G; Koev D Exp Clin Endocrinol Diabetes; 2001; 109(7):355-60. PubMed ID: 11573145 [TBL] [Abstract][Full Text] [Related]
17. Impaired insulin secretion in non-diabetic offspring of probands with latent autoimmune diabetes mellitus in adults. Vauhkonen I; Niskanen L; Knip M; Ilonen J; Vanninen E; Kainulainen S; Uusitupa M; Laakso M Diabetologia; 2000 Jan; 43(1):69-78. PubMed ID: 10663218 [TBL] [Abstract][Full Text] [Related]
18. [Insulin secretion in normal individuals and in diabetics]. Johansen K Ugeskr Laeger; 1977 Apr; 139(16):933-9. PubMed ID: 322368 [No Abstract] [Full Text] [Related]
19. The stages of type 1A diabetes: 2005. Gianani R; Eisenbarth GS Immunol Rev; 2005 Apr; 204():232-49. PubMed ID: 15790362 [TBL] [Abstract][Full Text] [Related]
20. First-degree relatives of patients with type I diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion. Srikanta S; Ganda OP; Rabizadeh A; Soeldner JS; Eisenbarth GS N Engl J Med; 1985 Aug; 313(8):461-4. PubMed ID: 3894969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]